SCHEMBL20161429

SCHEMBL20161429

O=C(O)CC1O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]1O

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LGALS1 P09382 2/20 0.48
LGALS3 P17931 2/20 0.48
LGALS9 O00182 1/20 0.48
LGALS8 O00214 1/20 0.48
CA12 O43570 2/20 0.47
CA1 P00915 2/20 0.47
CA2 P00918 2/20 0.47
CA4 P22748 2/20 0.47
CA5A P35218 2/20 0.47
CA7 P43166 2/20 0.47
CA9 Q16790 2/20 0.47
CA3 P07451 1/20 0.47
CA13 Q8N1Q1 1/20 0.47
CA14 Q9ULX7 1/20 0.47
SELP P16109 1/20 0.47
PYGB P11216 7/20 0.46
GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7199426 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8CA12
SCHEMBL28909019 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8CA12
SCHEMBL20161428 1.00 LGALS1 (0.48) LGALS1LGALS3LGALS9LGALS8CA12
SCHEMBL7074760 0.98 CA12 (0.45) LGALS1LGALS3LGALS9LGALS8CA12
SCHEMBL20888687 0.86 SELP (0.42) LGALS1LGALS3LGALS9LGALS8CA12
SCHEMBL18819645 0.86 SELP (0.42) LGALS1LGALS3LGALS9LGALS8CA12
SCHEMBL3291698 0.85 SELP (0.47) LGALS1LGALS3LGALS9LGALS8CA12
SCHEMBL27974501 0.85 SELP (0.47) LGALS1LGALS3LGALS9LGALS8CA12
SCHEMBL9125622 0.84 IDUA (0.38) LGALS1LGALS3LGALS9LGALS8SELP
SCHEMBL9125616 0.84 IDUA (0.38) LGALS1LGALS3LGALS9LGALS8SELP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11045411-B2 Process for treating keratin materials using amide, acid or ester c-glycoside derivatives, and cosmetic composition containing same L'OREAL (FR) 2021-06-29 US disclosed
US-20180133137-A1 PROCESS FOR TREATING KERATIN MATERIALS USING AMIDE, ACID OR ESTER C-GLYCOSIDE DERIVATIVES, AND COSMETIC COMPOSITION CONTAINING SAME L'OREAL (FR) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180133137-A1 PROCESS FOR TREATING KERATIN MATERIALS USING AMIDE, ACID OR ESTER C-GLYCOSIDE DERIVATIVES, AND COSMETIC COMPOSITION CONTAINING SAME KRT18, CUTA, GLA LGALS1 408/4885LGALS3 403/4885LGALS9 567/4885
US-11045411-B2 Process for treating keratin materials using amide, acid or ester c-glycoside derivatives, and cosmetic composition containing same KRT18, CUTA, GLA LGALS1 408/4885LGALS3 403/4885LGALS9 567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.